News Agency
Men's Weekly

Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

  • Written by PR Newswire
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human StudyContinuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes

CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to advance...

Read more: Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform...

Supporting International Sales Enablement Through Structured Content

In an international selling environment, companies must contend with different languages, cultural differences, regulations, and varying buyers. As such, sales enablement goes beyond a folder of brochures and presentations but needs to be a scalable solution for message uniformity, easily... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion